BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 29476441)

  • 21. Age related axonal neuropathy in spinocerebellar ataxia type 3/Machado-Joseph disease (SCA3/MJD).
    Klockgether T; Schöls L; Abele M; Bürk K; Topka H; Andres F; Amoiridis G; Lüdtke R; Riess O; Laccone F; Dichgans J
    J Neurol Neurosurg Psychiatry; 1999 Feb; 66(2):222-4. PubMed ID: 10071104
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Association of serum neurofilament light and disease severity in patients with spinocerebellar ataxia type 3.
    Peng Y; Zhang Y; Chen Z; Peng H; Wan N; Zhang J; Tang J; Wang P; Xie Y; Cai Q; Liu S; Zhang X; Wang C; Yuan H; Li T; Wan L; Shi Y; Qiu R; Klockgether T; Tang B; Liao W; Jiang H
    Neurology; 2020 Dec; 95(22):e2977-e2987. PubMed ID: 32817181
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Hypothalamic Atrophy, Expanded CAG Repeat, and Low Body Mass Index in Spinocerebellar Ataxia Type 3.
    Guo J; Jiang Z; Biswal BB; Zhou B; Xie D; Gao Q; Sheng W; Chen H; Zhang Y; Fan Y; Wang J; Liu C; Chen H
    Mov Disord; 2022 Jul; 37(7):1541-1546. PubMed ID: 35426475
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Facial grimacing and clinical correlates in spinocerebellar ataxia type 3.
    Rezende Filho FM; Vale TC; Pedroso JL; Braga-Neto P; Barsottini OG
    J Neurol Sci; 2019 Feb; 397():138-140. PubMed ID: 30616057
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Body composition in Spinocerebellar ataxia type 3 and 10 patients: Comparative study with control group.
    Leite CMBA; Schieferdecker MEM; Frehner C; Munhoz RP; Ashizawa T; Teive HAG
    Nutr Neurosci; 2020 Jan; 23(1):49-54. PubMed ID: 29734917
    [No Abstract]   [Full Text] [Related]  

  • 26. Cytokines in Machado Joseph Disease/Spinocerebellar Ataxia 3.
    da Silva Carvalho G; Saute JA; Haas CB; Torrez VR; Brochier AW; Souza GN; Furtado GV; Gheno T; Russo A; Monte TL; Schumacher-Schuh A; D'Avila R; Donis KC; Castilhos RM; Souza DO; Saraiva-Pereira ML; Torman VL; Camey S; Portela LV; Jardim LB
    Cerebellum; 2016 Aug; 15(4):518-25. PubMed ID: 26395908
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Motor cortical dysfunction develops in spinocerebellar ataxia type 3.
    Farrar MA; Vucic S; Nicholson G; Kiernan MC
    Clin Neurophysiol; 2016 Nov; 127(11):3418-3424. PubMed ID: 27689815
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The correlation between magnetic resonance imaging features of the brainstem and cerebellum and clinical features of spinocerebellar ataxia 3/Machado-Joseph disease.
    Liang X; Jiang H; Chen C; Zhou G; Wang J; Zhang S; Lei L; Wang X; Tang B
    Neurol India; 2009; 57(5):578-83. PubMed ID: 19934555
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Mutations in American families with spinocerebellar ataxia (SCA) type 3: SCA3 is allelic to Machado-Joseph disease.
    Higgins JJ; Nee LE; Vasconcelos O; Ide SE; Lavedan C; Goldfarb LG; Polymeropoulos MH
    Neurology; 1996 Jan; 46(1):208-13. PubMed ID: 8559377
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Spinocerebellar ataxia 3 and Machado-Joseph disease: clinical, molecular, and neuropathological features.
    Dürr A; Stevanin G; Cancel G; Duyckaerts C; Abbas N; Didierjean O; Chneiweiss H; Benomar A; Lyon-Caen O; Julien J; Serdaru M; Penet C; Agid Y; Brice A
    Ann Neurol; 1996 Apr; 39(4):490-9. PubMed ID: 8619527
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Serum concentrations of NSE and S100B in spinocerebellar ataxia type 3/Machado-Joseph disease.
    Zhou J; Lei L; Shi Y; Wang J; Jiang H; Shen L; Tang B
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2011 Jun; 36(6):504-10. PubMed ID: 21743141
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Six cases of SCA3/MJD patients that mimic hereditary spastic paraplegia in clinic.
    Wang YG; Du J; Wang JL; Chen J; Chen C; Luo YY; Xiao ZQ; Jiang H; Yan XX; Xia K; Pan Q; Tang BS; Shen L
    J Neurol Sci; 2009 Oct; 285(1-2):121-4. PubMed ID: 19608203
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Body Mass Index Is Significantly Associated With Disease Severity in Spinocerebellar Ataxia Type 2 Patients.
    Almaguer-Mederos LE; Pérez-Ávila I; Aguilera-Rodríguez R; Velázquez-Garcés M; Almaguer-Gotay D; Hechavarría-Pupo R; Rodríguez-Estupiñán A; Auburger G
    Mov Disord; 2021 Jun; 36(6):1372-1380. PubMed ID: 33548146
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Schwann cell involvement in the peripheral neuropathy of spinocerebellar ataxia type 3.
    Suga N; Katsuno M; Koike H; Banno H; Suzuki K; Hashizume A; Mano T; Iijima M; Kawagashira Y; Hirayama M; Nakamura T; Watanabe H; Tanaka F; Sobue G
    Neuropathol Appl Neurobiol; 2014 Aug; 40(5):628-39. PubMed ID: 23617879
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Spinocerebellar ataxia type 3/Machado-Joseph disease: segregation patterns and factors influencing instability of expanded CAG transmissions.
    Souza GN; Kersting N; Krum-Santos AC; Santos AS; Furtado GV; Pacheco D; Gonçalves TA; Saute JA; Schuler-Faccini L; Mattos EP; Saraiva-Pereira ML; Jardim LB
    Clin Genet; 2016 Aug; 90(2):134-40. PubMed ID: 26693702
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A neurological examination score for the assessment of spinocerebellar ataxia 3 (SCA3).
    Kieling C; Rieder CR; Silva AC; Saute JA; Cecchin CR; Monte TL; Jardim LB
    Eur J Neurol; 2008 Apr; 15(4):371-6. PubMed ID: 18312406
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Genetic risk factors for modulation of age at onset in Machado-Joseph disease/spinocerebellar ataxia type 3: a systematic review and meta-analysis.
    de Mattos EP; Kolbe Musskopf M; Bielefeldt Leotti V; Saraiva-Pereira ML; Jardim LB
    J Neurol Neurosurg Psychiatry; 2019 Feb; 90(2):203-210. PubMed ID: 30337442
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Depression and clinical progression in spinocerebellar ataxias.
    Lo RY; Figueroa KP; Pulst SM; Perlman S; Wilmot G; Gomez C; Schmahmann J; Paulson H; Shakkottai VG; Ying S; Zesiewicz T; Bushara K; Geschwind M; Xia G; Yu JT; Lee LE; Ashizawa T; Subramony SH; Kuo SH
    Parkinsonism Relat Disord; 2016 Jan; 22():87-92. PubMed ID: 26644294
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Nystagmus may be the first neurological sign in early stages of spinocerebellar ataxia type 3.
    Gama MTD; Rezende Filho FM; Rezende TJR; Braga Neto P; França Junior MC; Pedroso JL; Barsottini OGP
    Arq Neuropsiquiatr; 2021 Oct; 79(10):891-894. PubMed ID: 34706018
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Characterization of Lifestyle in Spinocerebellar Ataxia Type 3 and Association with Disease Severity.
    Hengel H; Martus P; Faber J; Garcia-Moreno H; Solanky N; Giunti P; Klockgether T; Reetz K; van de Warrenburg BP; Pereira de Almeida L; Santana MM; Januário C; Silva P; Thieme A; Infante J; de Vries J; Lima M; Ferreira AF; Bushara K; Jacobi H; Onyike C; Schmahmann JD; Hübener-Schmid J; Synofzik M; Schöls L
    Mov Disord; 2022 Feb; 37(2):405-410. PubMed ID: 34713931
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.